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This exploratory study seeks to explore the current state of design for the environment (DfE) in the
development of medical devices; an historically risk averse industry that lags behind others in terms of
addressing environmental considerations. A cross-sectional survey of 34 medical device designers, pri-
marily in the UK and USA, was conducted in order to fulﬁl this objective. Findings indicate that there is
signiﬁcant motivation to enhance DfE practice, but that there are multiple barriers to this. Major barriers
identiﬁed are a perception of the high cost of DfE, the industry's current reliance on a single-use business
model for many current products and a lack of education about DfE topics on all sides. Designers felt that
the most signiﬁcant opportunities to implement DfE are in situations where they are able to exert direct
control, mainly in the early stages of the design process. Issues noted include raw material choice and
packaging decisions. The nature of single use business models is also critical, pointing towards the needs
for a systemic rather than product focus. For this to be achieved, ﬁnancial rewards must be evident to
ﬁrms and the changing regulatory landscape might also make a more signiﬁcant impact.
© 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
As part of the wider effort to create a more sustainable mode of
existing, businesses are under increasing pressure to produce
environmentally benign goods and services. Research activity in
this area has been growing and as a result, more environmentally
conscious products are being developed and consumed (e.g. Albino
et al., 2009). The importance of eco-design in industry is not
disputed and efforts are increasing to provide support or guidance
to ﬁrms (e.g. Pigosso et al., 2013). However, there is little evidence
of work speciﬁcally targeted at themedical device sector. This study
is thus explicitly concerned with better understanding environ-
mentally conscious design in the medical device sector, where the
investment required in developing new products is very large and
the environmental impact of devices is highly signiﬁcant. For
example, it is reported by Kadamus (2008) that 6600 tons (short
tons, 1 short ton ¼ 2000 lb or approximately 907 kg) of medical
waste are generated every day by healthcare facilities in the US,
much of which comprises medical devices. A large portion of this
waste is considered hazardous, since it has been in contact with the).
r Ltd. This is an open access articlebodily ﬂuids of patients. Approximately 12% of this waste is non-
hazardous plastic. Other environmental issues include the use of
rare or harmful materials. For example, healthcare is the fourth
largest contributor of mercury to the environment and a signiﬁcant
contributor of dioxins, another serious environmental pollutant
(Zimmer andMcKinley, 2008). Yet, it is reported that the healthcare
sector in general has lagged behind other industries in the area of
implementing environmentally conscious practices and literature
on the subject is scarce (Karlsson and Ohman, 2005).
There are growing legislative pressures on the medical device
industry to eliminate or reduce the impact of waste and especially
of hazardous or toxic substances. Throughout the EU, all electrical
devices are subject to the Waste Electrical and Electronic Equip-
ment Directive (EU Directive, 2012/19/EC),1 and this piece of
legislation is closely tied with another ruling, the Restriction of
Hazardous Substances Directive (EU Directive, 2012/19/EC),2 which
restricts the use of some materials deemed dangerous in the
manufacture of electrical items. Medical devices can be exempt
from this legislation if they are expected to be ineffective as a result.
Medical devices are covered by The EU's 2009 Ecodesign Directive1 http://eur-lex.europa.eu/legal-content/EN/TXT/?uri¼CELEX:32012L0019.
2 http://eur-lex.europa.eu/legal-content/EN/TXT/?uri¼CELEX:32002L0095.
under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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energy-related products and includes the explicit consideration
during the design phase.
Recognising that there is a signiﬁcant problem where the de-
signers of medical devices play an important role. But, there is little
evidence regarding the knowledge and awareness of environ-
mental concerns amongst these designers. Through this work we
aim to take ﬁrst steps in exploring the state of environmentally
conscious design in the medical device industry, which is so far
little discussed in the literature.1.1. Deﬁnitions and terminology
Deﬁnitions of medical devices vary among different geograph-
ical areas, but in general they include articles manufactured spe-
ciﬁcally for diagnostics, monitoring, treatment, or modiﬁcation of
the human body, that are not solely pharmaceutical goods.
In the United States, medical devices are controlled and regu-
lated by the FDA (Food and Drug Administration). In Europe,
regulation is slightly more complicated, because the deﬁnition of a
medical device is provided by the EU, but individual countries take
on the task of approving devices for use inside their own borders
(e.g. the MHRA (Medicines and Healthcare products Regulatory
Agency) in the United Kingdom). USA and European deﬁnitions for
medical devices are given below, since these are the two largest
markets for medical devices (Epsicom, 2011a,b).Table 1
Examples of medical devices (Hong, 2010).
Class Description Example
Class 1 Medical devices with minimal potential harm Stethoscope (mechanical), thermometer (capillary, mercury), Centrifuge (tabletop)
Class 2 Medical devices with low potential harm Stethoscope (electronic), Thermometer (electronic), Electroencephalograph, CT system,
Electrocardiographic analyser
Class 3 Medical devices with moderate potential harm Bone absortiometric ultrasound system, Condon, Haemiodialysis system, Prosthesis vascular
(peripheral)
Class 4 Medical devices with high potential harm Prosthesis vascular (central), Breast prosthesis (internal, gel-ﬁlled), Orthopaedic ﬁxation plate
(biodegradable) In Europe, a medical device is deﬁned as “Any instrument,
apparatus, appliance, software, material or other article, whether
used alone or in combination, together with any accessories,
including the software intended by its manufacturer to be used
speciﬁcally for diagnostic and/or therapeutic purposes and
necessary for its proper application, intended by the manufac-
turer to be used for human beings for the purpose of: diagnosis,
prevention, monitoring, treatment or alleviation of disease;
diagnosis, monitoring, treatment, alleviation of or compensation
for an injury or handicap; investigation, replacement or modiﬁ-
cation of the anatomy or of a physiological process; control of
conception and which does not achieve its principal intended
action in or on the human body by pharmacological, immuno-
logical or metabolic means, but which may be assisted in its
function by such means.” (European Union, 2007).
 In the US, the FDA deﬁnes medical devices as “An instrument,
apparatus, implement, machine, contrivance, implant, in vitro
reagent, or other similar or related article, including a compo-
nent part, or accessory which is: recognized in the ofﬁcial Na-
tional Formulary, or the United States Pharmacopoeia, or any
supplement to them; intended for use in the diagnosis of disease3 http://eur-lex.europa.eu/legal-content/EN/TXT/?
qid¼1407837072522&uri¼CELEX:32009L0125.or other conditions or in the cure, mitigation, treatment or
prevention of disease in man or other animals; or intended to
affect the structure or any function of the body of man or other
animals, and which does not achieve any of its primary intended
purposes through chemical action within or on the body of man
or other animals and which is not dependent upon being
metabolized for the achievement of any of its primary intended
purposes” (FDA, 2011a).
Europe and the US are the leaders in the medical device world
and these two deﬁnitions amount to much the same thing. Other
countries use broadly similar deﬁnitions (for example Australia's,
which can be found in their Therapeutic Goods Act, 1989), and
means that there is little if any ambiguity in understanding what is
meant by a medical device for research purposes. The deﬁnition is,
however, necessarily broad, and covers a wide range of complexity;
from simple tongue depressors, through syringes, blood pressure
monitors, surgery tools up to large X-ray or MRI (magnetic reso-
nance imaging) machines with many components.
In setting out the breadth of devices encompassed in these
deﬁnitions, Hede et al. distinguish between class I devices (e.g.:
tongue depressor) which are subjected to the least regulatory
controls and Class III devices (e.g.: cardiac pacemaker) which must
adhere to the most stringent regulatory controls, as they present a
higher degree of risk to human health in cases of malfunction or
erroneous use (Hede et al., 2013), see Table 1.Designing with the environment in mind also comes with a
wide range of terminology; Design for Environment (DfE), ecode-
sign, green design, environmentally conscious design and more
(Braungart et al., 2007). Alongside this plethora of terminology is a
correspondingly wide range of deﬁnitions (Fletcher and Goggin,
2001). Despite the multitude of deﬁnitions available for these
terms, they are all geared towards generating better environmental
outcomes through design. In this work, the terms “DfE” and
“environmentally conscious design” have been used to encompass
these ideas, although the other terms, where they are used are
intended to be interchangeable with these.1.2. Development of environmentally conscious medical devices
Developing medical devices is complex, ﬁnancially risky, re-
quires large upfront investment and involves long lead times to
market (Medina et al., 2013; Pietzsch and Pate-Cornell, 2008;
Johnson and Moultrie, 2012). Most devices that enter clinical trials
will fail before they reach the market and those that do end up on
sale will have been through a lengthy and difﬁcult testing process
to ensure that the high standards required for use in humans are
met. Rigorous (and necessary) focus on safety and efﬁcacy has
meant that efforts to minimise environmental impact are often de-
prioritised or postponed (Medina et al., 2013). In this respect, it is
widely believed that the healthcare industry lags behind other
4 Examples include Health Care Without Harm (http://www.noharm.org), The
Climate and Health Council (http://www.climateandhealth.org) and The Centre for
Sustainable Healthcare (http://sustainablehealthcare.org.uk).
5 e.g. Novo Nordisk: Our Triple Bottom Line. Retrieved 10 18, 2012, from http://
www.novonordisk-us.com/documents/article_page/document/Triple_Bottom_Line.
asp.
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2005).
Despite lagging behind other industries in DfE activity, the
medical device industry faces sustainability concerns common to
the design process in many commercial areas; those around energy
use, waste, consumption of scarce materials, consequences of waste
and so on. These issues are relevant across all stages of the product
life cycle from the extraction of raw materials, through manufac-
ture, distribution, use and end of life. On top of this, the medical
device industry faces some issues speciﬁc to healthcare and these
are tightly tied with the process of new product design. Some of
these major concerns are described below:
 Waste: The healthcare sector generates multiple and complex
waste streams (Zimmer andMcKinley, 2008). Several small scale
studies or estimation exercises (e.g. Kadamus, 2008; Hutchins
and White, 2009) have been undertaken, showing that vast
amounts of waste are produced by medical facilities and that
typically, much waste that ends up in sharps or biological waste
bins is uncontaminated and could be disposed of through other
means or recycled. Not only is there a clear opportunity for
improvement on a purely environmental basis, but waste that is
disposed of as hazardous and as a result is expensive to process
(e.g. NHS Sustainable Development Unit, 2010; Zimmer and
McKinley, 2008).
 Toxic substances: As well as concerns around waste, the industry
faces growing pressure to eliminate toxic or hazardous sub-
stances, particularly mercury, from its products (EU, 2007).
Other substances such as polyvinyl chloride (PVC) have also
come under increasing scrutiny. PVC in particular has been the
focus of attention since the phthalates used to soften the plastic
can leach into substances with high lipid content and exposure
to high doses of these phthalates can lead to reproductive
problems as well as toxic effects in the heart, lungs and kidneys
(Tickner et al., 2001). There is some debate about the level of risk
actually posed to human health, but in the face of controversy
about these chemicals, it is likely that the medical device in-
dustry will be expected to respond to these concerns and design
products accordingly. As substances like these become subject
to stronger controls from regulatory bodies, it is likely that
regulation in other areas will also tighten. Medical devices were
previously exempted from the EU Waste Electrical and Elec-
tronic Equipment Directive, which governs the end of life re-
quirements for electrical goods in the EU. However, since 2012
medical devices are no longer exempt unless they will become
bio-hazardous during the course of their use (Directive 2012/19/
EU), and the healthcare industry in the EUwill have to change to
accommodate this. This, alongside increasing producer re-
sponsibility obligations in general, will put pressure on the
medical device manufacturing industry (Marshal et al., 2009).
 Single use business model: Closely tied with issues surrounding
waste disposal is the industry's favoured single-use device
businessmodel. During the 1980s and 1990s businessmodels for
single-use devices began to emerge. Many products are marked
by the manufacturer for use only once and so they are discarded
when they have been opened, irrespective of whether they have
been usedwith a patient. This practice generates huge quantities
of waste and single-use medical devices have been under close
scrutiny in this respect for several years (Stripple et al., 2008). In
many cases disposal is appropriate (e.g. where a device that
cannot be sterilised comes into contact with bodily ﬂuid), but in
other cases safe reuse is possible, even though the product is
marked as single-use. In the US, organisations that take care of
the safe reprocessing of single-use devices have started to
emerge (e.g. Stryker Sustainability Solutions), although theuseofreprocessed devices is far from common place, and is otherwise
virtually unheard of in the westernworld.
The topics discussed here do not by any means represent all the
issues facing designers in the medical device industry seeking to
implement DfE, but these major areas are the starting point for
discussion. However, this discussion is currently very much in its
infancy within the industry, despite the presence of organisations
advocating greener practice in the healthcare industry in general.4
As a result, it is difﬁcult to uncover much evidence of environ-
mentally conscious product design in the medical device industry.
There are a few isolated published or documented examples of
deliberate DfE work in the industry such as Hanson and Hitchcock
(2009), and the environmentally friendly syringe “Syreen”
designed by Engineering Consultancy, Cambridge Consultants
Limited (www.cambridgeconsultants.com) but by and large, the
medical device design industry is only just getting started in this
area. Individual companies may promote their own environmental
credentials, albeit often as part of an overall commercial strategy.5
Furthermore, the isolated nature of individual case examples
demonstrates the lack of knowledge about environmentally
conscious design practice in themedical device industry as awhole.
This lack of case-studies is signiﬁcant, as designers by their nature
take inspiration from prior design work.
The characteristics of environmental impacts vary by industry
sector, as do the opportunities for improvement (Vezzoli and Sciama,
2006; Pearson, 2008). Thus, in order to make improvements in the
medical device sector, it is necessary to focus on design issues of
speciﬁc relevance to this sector alone. In conjunction with industry-
speciﬁc design concerns, it is also necessary to understand
the motivating factors to practise DfE in the ﬁrst place. Previous
work by (e.g.) Borchardt et al. (2010) demonstrates that factors
inﬂuencing theuseofDfEmaybe internal or external to the company
in which the design takes place. Internal factors would typically be
company such as management initiatives; external pressures
would be issues such as client or user demands, regulatory re-
quirements and national (or international) level governmental
pressure. With this approach in mind, this study aimed to assess the
current state of DfE practice in the medical device industry. It is
believed that this ‘baseline’ of understanding is a critical foundation
on which to build further understanding of how, ultimately, more
environmentally benign medical devices might be created.2. Method
To address the gap articulated above, this exploratory study
speciﬁcally aimed to:
1. Explore designers' attitudes to DfE in medical devices
2. Understand which areas of DfE designers felt were most rele-
vant to their work
3. Establish what, if any, DfE in medical devices they had
undertaken
4. Discover whether medical device designers use any tools to help
them in pursuit of DfE objectives
5. Gather opinion about DfE in medical devices from practitioners
in the ﬁeld more generally
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signers was conducted to gather information on current DfE prac-
tices and understand trends and perceptions in the medical device
industry. This approach was chosen in preference to interviews
with individual designers, as it was felt that whilst this might yield
detailed data, it would by its very nature provide only a very narrow
view into practices in this ﬁeld. In addition, selecting speciﬁc can-
didates for interview who are representative of their peer group
would have been problematic. Indeed, the danger of an interview
based approach would have been the selection of candidates for
interview who by their expressed interest in the subject might be
adopting more advanced practices than some of their colleagues.
Also, it is sometimes difﬁcult to compare data from semi-structured
interviews, which by their nature enables the interviewer to follow
new leads and explore new territory as a conversation progresses.
Instead, the intention of this study was to collect comparable evi-
dence from as many medical device designers as possible, in order
to address the gap perceived in knowledge which characterises a
wider set of practices across this sector. In fulﬁlling these objec-
tives, the survey collected data fromwithin the industry, examining
both internal practices at the companies in which the designers
were working and external factors that may inﬂuence the de-
signers. The target audience for this survey was practising or ex
medical device designers.
The survey was designed and distributed using online survey
tools from Qualtrics (www.qualtrics.com) and was presented in a
neutral colour scheme. Questions were arranged into short sec-
tions, with the intention that questions progressed from general to
speciﬁc. In addition, questions that were viewed as most valuable
to the study were placed towards the beginning of the question-
naire, to increase the likelihood of gaining useful responses. Sec-
tions were as follows:
 Introduction: An introductory message summarising the context
for the survey which offered background information and
assured of participant conﬁdentiality.
 Screening question: As an online survey, it is possible that it
might be completed by respondents not in the target group. In
order to ensure that only people in the target group responded
to the survey, a screening question was included; “Are you, or
have you been, involved in the design of medical devices?”
Thosewho failed the screening questionwere excluded from the
rest of the survey.
 About you: Participants were asked some basic details about
their job and the organisation for which they worked.
 Designing for environmental sustainability: This section asked
about the drivers of DfE practice and how important partici-
pants perceived it to be. In addition, participants were asked to
identify the major barriers to DfE implementation and whether
or not participants had used any tools to assist in the imple-
mentation of DfE principles.
 Sustainability concerns: Designers were asked how important a
variety of speciﬁc DfE issues were in their work and whether or
not they had addressed those issues in the design of previous
medical devices.
 Further comments: Participants were invited to leave any further
thoughts on the topic of DfE in medical devices.
 Demographic information: Finally, respondents were asked for
information about their location, age and gender, as well as the
size of the ﬁrm in which they worked.
The survey was initially piloted using a group of ten subject-
naive people, in order to check that questions were unambiguous
and that the instructions were correctly interpreted by participants.
The release version of the survey was then ﬁnalised, incorporatingnecessary modiﬁcations from the pilot phase. The survey was
distributed by giving potential participants a link to the survey's
online location. The full survey is reproduced in the Appendix to
this paper.
Online distributionwas considered themost desirable option on
the grounds of cost, speed of response collection and ease of sec-
ondary participant recruitment (recruitment of people who were
not sent the link ﬁrst hand by the researchers). Participants were
recruited by email, or in person, beginning with industry pro-
fessionals known to the authors and their immediate contacts.
Potential participants contacted in this way were invited to pass on
the web link for the survey to others. Participants were also
recruited through the alumni network at the University of Cam-
bridge and via posts in online forums for medical device engineers.
It was believed that ensuring participant anonymity was necessary
in order to gain responses. However, a downside of this approach is
that it almost impossible to identify the speciﬁc mechanism by
which a particular respondent became aware of the study and thus,
we have no data on the success of each of the various participant
recruitment strategies.
The survey was ‘live’ online for a period of two months after
which it survey was closed and results were drawn together for
analysis. Two months was believed to be a sufﬁcient period of time
to ensure that the survey was both circulated widely and that po-
tential respondents were given sufﬁcient time to respond. During
this period, frequent reminders were sent using the mechanisms
described above.
3. Sample
42 people responded to an invitation to take the survey, eight of
whom were eliminated by the preliminary screening question
(Appendix, Q1.1). Respondents who had completed the screening
question successfully but left no further information or left re-
sponses consisting only of nonsense character strings, were elimi-
nated at the outset and are not included in the 42 responses
referred to above. This left 34 complete responses to the survey
from people who were in the target group e medical device
designers.
Respondents included 29 men and 5 women. 88% of re-
spondents were in the United Kingdom and 12% were in the United
States. The majority of respondents (64%) were aged between 25
and 34 years, although there were exceptions in both directions.
Participants worked for organisations that varied in size from a
single person to more than 1000 employees, the modal class being
organisations with between 11 and 50 employees, to which 44% of
respondents belonged. 67% of respondents had worked in an in-
dustry unconnected to medical devices at some point in their
career; 33% had worked solely in the medical device arena. Re-
spondents had self-identiﬁed as having experience in the design of
medical devices. Of the 34 respondents, 12 were from technology
based ﬁrms with a background in the medical sector, 10 were from
speciﬁc medical technology ﬁrms, 10 were from design service
ﬁrms with a specialism in medical devices and the remaining 2
were in the healthcare sector. The majority of respondents were
designers or design engineers (7), some at a more senior level (7).
Six respondents described themselves as consultants/senior con-
sultants. The remaining respondents included 4 researchers, 3 Di-
rectors/CEOs, 2 in commercial management, 2 in project
management and 3 ‘others’.
No attempt was made to specify or constrain respondents in
terms of the speciﬁc nature of the medical devices which they
design. Issues around environmental design are relevant to the
development of all devices, whether they are complicated electro-
mechanical machines or simple solutions.
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comparatively small, it is also necessary to note that this is a very
specialist ﬁeld. The majority of respondents are also comparatively
young and this may well reﬂect the approach taken to data
collection. Overall, we believe that this sample is characteristic of
the sector and that the responses are representative. However, we
also recognise that care must be taken in generalising the results to
be reﬂective of the whole population.4. Results and analysis
Due to the nature of the data collection method, the sample
represents English-speaking designers who had either been
touched directly by one of the recruitment methods detailed in the
previous section, or had had the survey link passed to them. It is
inevitable that some designers will have felt more inclined to ﬁll in
a survey about environmentally conscious design than others and
some of these might well have had at least a passing interest in
sustainability. This does not necessarily mean that all participants
had a special afﬁnity with the subject matter, but it is impossible to
tell to what extent this inﬂuenced the data, and there is no control
for this in the analysis process. In detailing these results, a mixture
of straightforward graphical representations, statistical techniques
and quotes from participants have been used, where appropriate, in
line with the spectrum of questions posed.4.1. Attitudes to DfE
16 respondents indicated that they thought the impetus to
design for the environment was increasing; a further 16 believed
that it was “remaining about the same”, and the remaining 2
thought that it was decreasing. This is shown in Fig. 1. We might
conclude from this that there is substantial belief that the need to
consider the environment is increasing, but also that there is still a
belief among designers that it is not increasing.
Participants were asked to score a list of ﬁve potential drivers for
action in DfE, derived from literature as described in the intro-
duction. In addition to these factors, a further driver was added to
account for the case that the designer felt personally motivated to
design for the environment, in addition to other factors. Scoring
was on a scale from 0 to 100with 0 indicating that the issuewas not
a driver for DfE, 100 indicating a very strong driver. Participants
were also offered the option to specify another driver and to rate
this in the same way. Respondents placed the given drivers in the
following order (strongest to weakest).Fig. 1. Survey participants' opinions on the impetus to design for the environment
(n ¼ 34). Other (explained further below)
 Regulatory mandate
 Client demand
 Pressure from government organisations
 Individual choices of designers
 Internal company pressure
The importance values assigned to these drivers are shown in
Fig. 2.
It is interesting to note that the dominant drivers for DfE are
‘external’ to the ﬁrm. Indeed, the designer's intrinsic motivation is
actually viewed as more inﬂuential than pressurewithin the ﬁrm. It
might be speculated that this lack of company motivation is driven
by ﬁnancial gains due to a predominantly singly-use business
model. It also highlights that without external pressure, change is
unlikely to come from within, unless the ﬁrm perceives clear
competitive advantage.
The ‘other’ category accounts for a broad spread of ideas and
interests which respondents felt was not encapsulated in the ﬁve
notions presented. Interestingly, where respondents had chosen to
add their own driver, they always assigned this the highest score;
presumably because they felt that an important issue had been
missed. Issues raised in this way included:
 Cost reduction (3 respondents)
 Problems with raw materials (1 respondent)
 Improvements in technology whichmake DfE less commercially
risky (1 respondent).
It should be noted that although the ‘other’ category overall is
dominant, we cannot say that these items individually are more (or
less) important than the ﬁve predetermined items.
Participants were then asked to identify how DfE manifested
itself in the work that they actually did, by choosing from a list of
statements that covered a range of scenarios (e.g. “it is not
important but we will comply with the law where we have to”).
Respondents were asked to select the description that they felt
best ﬁt their attitude towards DfE. These scenarios and the num-
ber of respondents choosing each option can be seen in Fig. 3. This
illustration shows that the most common scenario is that de-
signers choose to incorporate DfE practice into their work volun-
tarily, but that other things are more important. Overall, these
responses indicate that DfE is a low priority for designers, with
consideration only given when either they are required to by
either clients or legislation. This conﬁrms the views expressed in
Fig. 2.
4.2. Speciﬁc design issues
Participants were presented with a list of DfE considerations
generated from literature, broken down into product life cycle
phases to aid clarity. They were then asked to assign a score from
1 to 5 to indicate how important each issue was in their design
work (1 represented issues that were unimportant and 5 rep-
resented issues that were very important). Respondents were
also asked separately to what extent they had tacked the same
set of issues during the course of their work. Data from re-
sponses to these questions were used to rank the design issues
for both perceived importance and the extent to which the de-
signers in the sample had tackled them. A summary is given in
Table 2 and a plot detailing the two sets of ranks is given in
Fig. 4.
The two sets of ranks were analysed using Spearman's correla-
tion coefﬁcient to ascertain their level of covariance, in other words
to determine to what extent a high rank in one list was associated
Fig. 2. Drivers for DfE in medical devices (error bars represent 95% conﬁdence intervals for each mean) (n ¼ 34).
Fig. 3. How DfE manifests itself in the work of medical device designers (n ¼ 34).
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coefﬁcient for this data set was computed as rs ¼ 0.818 (t ¼ 7.79,
p < 0.001), indicating that there was a strong correlation between
the two sets of ranks, in other words, if designers considered a DfE
issue to be important, then they were also more likely to have
tackled it.
There are several places where there is a notable disparity be-
tween the ranks in the two lists for a particular design issue. These
can be seen as the outliers in Fig. 4 (these are circled). The points6 Spearman's rank was used since it could not be assumed that the underlying
data was normally distributed. An alternative analysis could have been conducted
by determining the Pearson productemoment correlation coefﬁcient for the un-
ranked data, but this test is more sensitive to outliers and requires that the data be
normally distributed.below and right of the main cluster represent over-implemented
issues (that is to say that they scored disproportionately highly
for having been addressed compared with their score for impor-
tance) and points above and left of the main cluster represent is-
sues that are under implemented (that is to say that they are
considered important but comparatively little action has been
taken to address them). Overall, there were fewer issues which
were viewed as ‘under-implemented’ compared with those that are
‘over-implemented. This suggests that designers might believe that
enough is being done to tackle key issues overall.
Under implemented issues include:
 Harmful substances in bill of raw materials: ranks 1st in impor-
tance, but 4th in level of implementation, suggesting room for
improvement.
Table 2
DfE issues ranked by importance and the degree to which they had been tackled (ranging from 1 unimportant to 5 very important).
Rank by mean
importance score
assigned by designers
Rank by whether
or not designers
had tackled the issue
Mean importance
score assigned by
designers
Number of designers
who had tackled
the issue
Life cycle phase Design issue
1 4 4.2 19 Raw material sourcing Harmful substances in bill of raw materials
2 16 3.9 10 Raw material sourcing Use of mercury
3 1 3.5 22 Use Lifetime/upgradeability
4 4 3.4 19 Use Single use components
5 4 3.3 19 Distribution Space efﬁciency of packaging
6 4 3.1 19 Distribution Amount of packaging
7 9 3.1 16 Manufacturing Processes used in assembly
8 9 2.9 16 Raw material sourcing Use of scarce materials (e.g. precious metals)
9 14 2.8 11 End of life Designed for reuse
10 2 2.8 20 End of life Designed for disassembly
11 2 2.8 20 Use Energy consumed during use (including
sterilisation requirements)
12 11 2.8 13 Manufacturing Solid waste produced
13 11 2.7 13 Distribution Materials used in packaging, including recyclability
14 8 2.7 17 Manufacturing Use of PVC
15 18 2.7 9 Distribution Method of transport
15 14 2.7 11 Use Solid waste produced
17 16 2.6 10 Manufacturing Processes used in raw material conversion
18 22 2.5 8 Manufacturing Waste water produced
19 18 2.5 9 End of life Designed for recyclability
20 13 2.5 12 Raw material sourcing Recycled, reused, or remanufactured content
20 18 2.5 9 Distribution PVC content of packaging
22 23 2.4 7 Use CO2 emissions during use
22 26 2.4 5 End of life Proportion which must be land-ﬁlled or incinerated
24 23 2.4 7 Distribution Distance from production site to buyer
25 9 2.4 16 Use Waste water produced
26 23 2.3 7 Manufacturing Energy sources used in assembly
27 26 2.3 5 Raw material sourcing Diversity of raw materials
28 29 2.2 2 End of life Designed for remanufacture
29 18 2.0 9 Manufacturing Energy sources used in conversion processes
30 28 1.9 4 Raw material sourcing Energy sources used in extraction
31 30 1.8 1 Raw material sourcing Processes of extraction
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implementation, which ranks second for importance but only
sixteenth for actually having been addressed.
Over-implemented issues include:
 Designed for disassembly: Ranked second highest for imple-
mentation and 10th for importance.
 Energy consumed during use: Ranked equal second for imple-
mentation and 11th for importance.
 Use of PVC: Ranked 14th for importance and 8th for level of
implementation.
 Waste water produced: ranked only 25th for importance but 10th
for level of implementation.
Other potentially over-implemented issues included addressing
the energy sources used in the conversion of raw materials and the
use of recycled/reused or remanufactured components in produc-
tion. It is also necessary to note that items which are fully imple-
mented become standard practice and as a result, their relative
importance would be expected to fall in comparison to new issues.
Responses were also analysed in order to ascertain whether
individual life cycle phases were considered signiﬁcantly more or
less important than the others, or had been tackled in preference to
the others. The raw scores from the questions about importance
were grouped according to life cycle phase and then subjected to
one-way ANOVA testing. No signiﬁcant difference in the mean
importance values assigned to issues was detected at the life cycle
phase level (F(4, 728) ¼ 1.62, p ¼ 0.168). Yes/no data for whether
individual design issues had been tackled was transformed into
numerical values, and then grouped by life cycle phase in the sameway as the importance scores, above. One-way ANOVA was then
conducted in order to see whether some life cycle phases had been
tackled in preference to others. This analysis showed that one or
more signiﬁcant differences existed between the means of the ﬁve
groups (F(4, 726) ¼ 5.05, p < 0.001). Post-hoc analysis using the
TukeyeKramer test revealed that both the distribution and end of
life phases had been tackled signiﬁcantly more than the extraction
of rawmaterials (p < 0.01). All other interactions were insigniﬁcant,
meaning that in general DfE effort had been spread fairly evenly
among the life cycle phases outside of the two interactions
mentioned previously.4.3. Barriers to implementing DfE in the medical device industry
Participants were asked what they perceived to be the major
barriers to the implementation of environmentally conscious design
in medical devices. Responses were collected using a free form text
ﬁeld. This led to answers of varying length and complexity. Since the
data collected was qualitative, the information was coded by ﬁrst
providing a broad or high-level classiﬁcation to each comment in
order to provide an initial grouping of ideas. Where more than one
idea was represented in a statement, then this was allocated to two
groups. These groups were then reviewed again until no new or
alternative groupings or themes emerged. These themes represent
the key barriers perceived by the designers in the sample and are
outlined below. The order in which they are listed is not signiﬁcant.
 Cost: this was by far the most commonly cited barrier (17 out of
34 respondents mentioned it in some form), although few
speciﬁed where these costs originated or with what they were
associated. Those that did also associated increased cost with
Fig. 4. Design issue ranks: importance assigned by designers against the degree to
which they had been tackled.
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mentally friendly materials, and the initial investment required
to move towards designing sustainably. One respondent said
that clients resisted extra costs associated with designing for the
environment. Another said: “The industry is very cost conscious.
Unless environmental considerations are enforced through
regulation they may not be considered unless the sustainable
options clearly positively affect revenue. In the medtech in-
dustry, where reimbursements are ﬁxed and in the current
climate may not be increased for the next year, the device/
consumable would need to be cheap as well as green.” This in-
dicates that DfE must support cost reduction rather than
contradict it if it is to cease to be a barrier. Other responses
indicate that this can indeed be the case: “Quite a lot of these
issues are just good design and save cost anyway.”
 Other design factors take priority: Some participants highlighted
the number of other things that they were asked to consider in
the design process as a reason for not actively practising design
for environment techniques; “We have so many other constraints
to ﬁt, it [DfE] often gets pushed aside.” Typically respondents
listed these other, to them more important considerations or
objectives, as safety, efﬁcacy and reliability.
 Client perceptions and demands: Some respondents referred to a
lack of client demand, or particular attitudes to the way in which
designing for the environment should be implemented: “There
seems to be an inherent fear of recycling anything biological
regardless of how it has been processed. It seems like clients are
more willing to have environmentally conscious design upfront
that minimises materials, shipping etc. than have to deal with
processing later.”
 Regulatory issues: One participant perceived regulatory activity
(in the UK) to be discouraging activity in DfE by encouraging
growth in the use of single-use devices. Two participants
expressed concerns over gaining regulatory approval to use
newly developed materials in medical devices. It was also noted
that once a device has been given regulatory approval, it is
difﬁcult to implement design changes retrospectively.
 Business model: Several respondents indicated that the current
business model in medical device manufacture (single-useitems or components rather than durable or reusable equip-
ment) was a hindrance to implementing environmentally
conscious design: “For medical devices, there is an ever
increasing trend towards increasing the amount of disposable
parts, driven by ease of use, sterility, and preference (by business
investors and users) for pay-per-use business models rather
than investment in durable equipment”
 Risk: In an historically risk averse industry, it is no surprise that
designers perceive the DfE arena as risky.4.4. Urgent DfE issues to tackle in the medical device industry
Participants were asked what they thought the most urgent
issues to tackle in the area of DfE for medical devices. Responses
were collected using a free form text ﬁeld and all responses were
coded using the same procedure described above. The resulting
concerns fell into four categories, which are detailed and discussed
below. Where appropriate, illustrative quotes are given from the
responses collected.
 Product-speciﬁc design issues: Many comments mentioned
product speciﬁc design issues. These ranged from the effective
use of materials, through the overuse of batteries to end of life
handling. Recycling and packaging were mentioned more than
other topics, and, in particular, packaging seemed to be an area
that was perceived as readily tackled: “I don't think there is any
excuse for not using environmentally low-impacting materials
and processes in medical device packaging.” A small number of
designers alluded to the need for greater understanding of how
third parties interact with medical devices, indicating that more
information or research may be needed in this area before
design improvements can be implemented.
 Education of designers and clients: This issue also appeared in
responses to the question about barriers to DfE implementation,
indicating that it is both important and problematic. “Educating
the manufacturers [clients] that intelligent design in a sustain-
able manner can save money.” Other responses indicated that
“freely available and consistent guidance” was necessary. This
supports the suggestion that designer education may be both
inconsistent and important.
 Business model: The concern most widely discussed was the
issue of the proliferation of single use devices, and the business
models that rely on the continued supply of single-use goods.
(The most common barrier to DfE implementation cited was the
cost involved e as described above). It was acknowledged by
many respondents that single-use medical devices can have
deleterious consequences for the environment: “This topic is a
tricky balance. When medical parts were all stainless steel,
reused and sterilised, there were issues with cross infection, and
costs of sterilisation. Single-use disposables are a safer product,
that in many ways can consume less energy, but will result in
landﬁll.” Several of the designers in the sample felt that this
issue should be the priority for DfE in medical device design,
saying that the top concern should be “ﬁnding out how to make
single-use disposable devices that are environmentally friendly.” At
the moment, it appears that there is greater incentive to stick to
a single-use model; “Sometimes products are deliberately
designed to be single-use to match the business model or to
make it easier for the user, even if functionally they could be
reused.” In addition, designers drew attention to the fact that,
although they may be able to design for DfE, the overall impact
of such work is dependent upon the cooperation of the whole
system, both locally and globally: “Whilst the blister packaging
used to package products is PETG and can be recycled, it is
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used to contain them. If the design is to be environmentally
friendly then the hospitals need to have systems in place to deal
with the designs/materials (…) Whilst legislation can force
manufacturers to be more environmentally friendly the end
user needs to have systems in place to perform this process.”
 Industry paradigm: Designers in the sample acknowledged the
industry setting as a function of their ability to change and shape
business models: “Sustainable design is still relatively new in
the product development industry, and is certainly not common
practice everywhere. It will take time for engineers and de-
signers to adjust their approach to produce more sustainable
designs, and it will take even longer for this to happen in con-
servative sectors such as medical, military and other high-
reliability applications.” And, “In countries or places where
these methods are not available it is easier for medical com-
panies to supply single-use devices that are less environmen-
tally friendly but clinically effective.”
Finally, it was acknowledged that a culture of cautious behav-
iour is present in the medical device industry and one designer
even singled this out as the most urgent issue to tackle.
4.5. Role of government and regulation
Comments from designers suggested that governments could
apply ﬁnancial pressure (either directly or indirectly) in order to
make the industry move towards more sustainable designs: “Make
it expensive to not be environmentally conscious and the market will
move very quickly.”
This could be done either by applying pressure directly to
manufacturers, or by applying pressure to end users (say, hospitals)
by, for example, making waste very expensive to dispose of, making
low-waste devices much more attractive to buyers. There is also
sentiment that suggests suchmoveswill have to be imposed, rather
than encouraged: “I am not expecting medical device manufac-
turers to go green unless the regulators force [it] upon them.”
This opinion contrasts with that of others in the sample who
placed different factors, such as the need for designer education or
revision of business models as the most important problem to
tackle. Overall, this implies that there is a wide range of attitudes
towards environmentally conscious designwithin the industry, and
thus potentially a wide range of levels of implementation.
5. Discussion and conclusions
Results show that there is motivation to design for the envi-
ronment in the medical design ﬁeld, although this is not consistent.
A large portion of the practitioners in the sample recognised that
there is a growing need to act upon environmental sustainability
issues in the design of medical devices, although a similarly large
proportion thought that this need was remaining static. The more
detailed questioning revealed that the prevalent attitude among
the sample was to implement DfE voluntarily, but to place other
considerations ﬁrst. Only a small minority said that they ‘do the
minimum’ to remain compliant with law, and there was some
indication that clients are increasingly requesting environmentally
conscious design. Taken together, these ﬁndings point towards
more DfE activity in the industry in future.
5.1. Drivers for DfE in the medical device sector
Results indicate that designers feel that themajor drivers for DfE
in the medical device industry are business imperatives; the law
and the wishes of the client. This is unsurprising, as failure torespond to either of these would result in serious problems at
organisational level. It is, notable, however that both the individual
choices of designers and pressure from governmental organisations
were considered to be more important than company initiatives,
indicating that in general, the perceptions and motivations of in-
dividuals to produce environmentally conscious designs are ahead
of co-ordinated policy and efforts from their companies as a unit.
This suggests that implementation of DfE principles could be pat-
chy, and will depend on the views of the particular designer, rather
than being guided at the company level.
Van Hemel and Cramer (2002), in their cross-industry survey,
also ﬁnd that client demand and regulatory issues are the top two
drivers for DfE activity, although they speciﬁcally identify lack of
client demand as a more important reason to delay DfE imple-
mentation than a lack of regulations. The medical designers in this
survey suggested that regulatory mandate was a stronger driver
than client demand. This is likely to be a consequence of both the
heavily regulated nature of themedical device industry and the lack
of user choice in the UK (where most of the survey respondents
were located, and where centralised healthcare in the form of the
NHS, means that decisions about which medical devices to use are
often taken away frompatients and sometimes from clinicians). It is
not known whether more importance would have been given to
client demand as a driver if more respondents had been from
countries without centralised healthcare.
It is not clear why internal company pressure is perceived as the
weakest of the drivers. Potential explanations include poorly
implemented or weak policy, policy that is overwhelmed by other
priorities or simply that policies do not exist at all. PR and press
attention were identiﬁed by respondents as an additional driver,
and it would be interesting to uncover how strong this inﬂuence is
in future work. This contrast between the desire for positive PR but
at the same time a lack of company pressure for DfE might suggest
that ﬁrms are seeking to persuade customers of their eco-
credentials but are not matching this with concerted action. The
notion that design constraints in non-DfE areas, such as safety, can
stimulate DfE activities as well as inhibiting it showing that DfE
activity can both complement and constrain wider design objec-
tives. In addition, the perceived riskiness of DfE as a strategy varies
among designers. Some see the risks reducing as environmentally
conscious technologies become more widely implemented and
trusted. It is evident that in order for DfE initiatives to be adopted,
they must ﬁrst and foremost deliver commercial or competitive
advantages to the ﬁrm. If these ﬁnancial rewards were more
evident, then action might become more of an internal driver.
5.2. Current DfE activity in the medical device sector
Statistical analysis of survey responses showed that if designers
considered a speciﬁc DfE issue to be important, theywere alsomore
likely to have tackled it. This ﬁnding is both logical and at the same
time slightly surprising. It is logical because issues that are
perceived to be important are naturally tackled ﬁrst. It is slightly
surprising since most of the literature points to an industry where
little DfE activity is taking place. It seems that some of the top
priorities are already receiving attention from designers, and this in
turn suggests that structures and systems for the incorporation of
DfE concerns may already exist in some companies. With the
exception of the inclusion of mercury in devices, the top few issues
for importance also scored well for having been tackled, similar to
Van Hemel and Cramer's (2002) study of eco-design in SMEs.
The issues that scored highly for importance are all issues that
designers can control directly and comparatively easily during the
early stages of the design process. Concerns that appeared at the
bottom of the importance list, also tended to have low scores for
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signers had little control, and which could not be reliably “designed
in” to a device. As an example, the inclusion of harmful substances
in the bill of rawmaterials was considered more important and had
been tackled by more designers than the processes involved in the
extraction of those materials.
The conﬁrmation that distribution and end of life issues had
been tackled signiﬁcantlymore than the extraction of rawmaterials
further supports the assertion that designers have tackled the is-
sues over which they have the most control in preference to others
since it is far easier to design “for” the distribution process (via good
packaging design) and for the product's end of life, than it is to
control the way raw materials are processed through the design of
the product. However, although designers may have a lack of direct
control, they do have a signiﬁcant inﬂuence through the materials
that they select.
Packaging in particular has relatively few barriers in terms of
DfE implementation, since designing with the environment in
mind generally means using less material, which supports cost
reduction, and is less important clinically, although sterility re-
quirements remain.
5.3. Difﬁculties in implementing DfE
The most prominent difﬁculty that emerged as a roadblock to
implementing DfE was that of perceived cost. Often those
commissioning the work (a client, or another department within a
company) had a pre-existing belief that DfE would mean additional
net expense. This perception must be dispelled either though ed-
ucation or demonstration if more work is to take place in the area.
Cost optimisation is a core business tenet, so DfE must support
work in this area if it is to achieve wider acceptance.
There were some suggestions that clients currently seem more
willing to accept DfE work at the front end of the product life cycle
than to face the more complex issues associated with the product's
end of life. The evidence for this, though, was anecdotal and war-
rants deeper investigation, given that it contradicts the ﬁndings
above, which suggest that end-of-life was one of the better-
addressed life cycle phases.
The reprocessing of single-use devices is currently discouraged
in the UK (the single-use business model is discussed inmore detail
below), and there was also some sentiment that newer materials
may cause regulatory difﬁculties if they are used in devices. In these
ways regulation is currently seen as a hindrance, but designers
could easily see ways inwhich regulation could be used to force DfE
rather than discourage it (e.g. by making it ﬁnancially punitive to
have devices with certain characteristics through either taxes or
ﬁnes). The potential impact of regulators in future is discussed
below.
The risk-averse nature of the medical device industry and the
perceived riskiness of DfE were identiﬁed as a major hurdle.
Research suggests that some risk aversion is justiﬁed since being
the ﬁrst to market with explicitly green products does not guar-
antee success (Marcus and Fremeth, 2009). Yet, it is highly likely
that while designers see, and respond to, the cautious nature of the
industry, in some cases they can also exploit areas in which the
perceived risk is starting to reduce, as DfE methods and practice
become more common place.
5.4. Issues in urgent need of tackling
The diversity of the issues that were perceived as urgent was
telling in itself; action is needed from government, from industry,
from companies and from individuals. At national level, the indi-
cation from some designers that regulatory intervention would benecessary to induce change indicates that on at least some level
there is a lack of forward motion in DfE implementation in the
medical device industry. There is some indication that regulation is
increasing (most medical devices fall under EU WEEE legislation
from 2012 onwards, as mentioned in Section 1.2) and as such it is
likely that there will indeed be regulatory push in some areas in the
future.
The discussion surrounding single-use medical devices is
evolving rapidly, and is likely to produce interesting conﬂicts be-
tween medical device manufacturers, whose income depends on
selling a steady stream of single-use goods, and hospitals and other
healthcare facilities that wish to cut costs as safely as possible while
maintaining patient conﬁdence in the treatment they receive.
Business incentives for manufacturers are currently largely to
remain with a single-use model. It is here that signiﬁcant effort is
needed as these problems are associated with a complex product
service system, in which the manufacturer is but one player
(Lindahl et al., 2013). The whole system must be addressed and not
just the ‘device’ in isolation. Thus, whilst individual ﬁrms may be
able to secure ﬁnancial returns for ecodesign (Plouffe et al., 2011), in
medical device development, the challenge is to focus on optimi-
zation of the whole system and not just the needs of an individual
player. Thus, a move towards product service systems offers the
potential to better address many environmental concerns, but to do
so demands cooperation from stakeholders which are currently
often in competitive or transactional role (Mont, 2002).
At the company level, there is a clear need to tackle the patchy
nature of designers' education around DfE topics. Many designers
admitted that they were looking for guidance, or said that their
clients (or other departments in the company) needed to better
understand the issues at hand before there would be a noticeable
change in the outputs of design work.
At the level of the individual designer, some issues were high-
lighted as “easy wins”, such as packaging, where it is fairly
straightforward to take into account clinical requirements while
drastically reducing the amount of material used, as discussed
above. It is highly likely that issues such as this will be tackled ﬁrst,
particularly where these design modiﬁcation can support cost
reduction strategies. Other urgent issues such as recycling are likely
to be more difﬁcult, and therefore slower, to implement, since they
require system change as well as design change to ensure that
designs that enable recycling actually result in the reprocessing of
the waste.
At all levels it was acknowledged that it will take time to see
changes within this highly conservative industry.5.5. Methodological limitations
Data collection was conducted solely online and only in English,
which restricted participation to English speakers with online ac-
cess. It is, however, unlikely that anyone actively engaged in the
commercial ﬁeld of medical device design routinely operates
without internet access. The online and anonymous format of the
survey also meant that there was no interaction between the re-
searchers and respondents. This prohibited any discussion of long
or complex responses. An attempt was made to counter the effects
of this by providing large text boxes for responses for open-ended
questions, nevertheless, this limitation remains.
Distribution of the survey's location via email and through the
internet came with an associated lack of control: once the web link
to the survey had been sent out for the ﬁrst time, the data gatherers
did not know with certainty whether those who had ﬁlled it in
were in the target group, despite the presence of a yes/no screening
question.
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population of medical device designers are unknown, it is difﬁcult
tomake assertions about how representative the samplewas of this
population. As discussed previously, it is likely that most, but not all
of the designers who ﬁlled in the survey had at least a passing in-
terest (if not necessarily knowledge) in sustainability. This, added to
the snowball style of recruitment described in Section 2, means
that the responses seen may collectively lean slightly towards the
perception that DfE is more important than if the entire population
had been surveyed.5.6. Conclusions and future work
This study aimed to take an important step towards exploring
the state of environmentally conscious design in themedical device
industry, to address a gap in the current knowledge of such prac-
tice. The survey gathered information from 34 medical device de-
signers, encompassing their motivation to design for the
environment, their experience with doing so and their major con-
cerns with respect to the environmental impact of their products.
Analysis of the data revealed that DfE in the medical device
industry is a complex mixture of standard environmental concerns
in a sector that lags far behind others in terms of implementation,
and considerations that are highly speciﬁc to this tightly regulated,
safety focused world. Although there is evidence that the medical
device industry lags behind others in terms of DfE implementation,
there is also evidence that DfE work is taking place, although it is
patchy in application. There is a need to educate both designers and
customers/users in the need for more environmentally sustainable
medical solutions, and in the appropriate techniques to develop
products to cater for this need.
As DfE comes to the fore in healthcare, the viability of the single-
use device business model will come under more scrutiny and
innovative new ways of addressing this problem will need to be
found. In particular this may point towards a move in the direction
of producteservice systems, and McAloone (2011) indicates that
more and more businesses (from across industries) are beginning
to consider this model as a serious business proposition. However,Section Question Question or text
Opening text This survey aims to explore h
interacting with environment
in the medical device world.
are, or have been, involved w
devices. The survey should ta
complete. We recognise that
faceted concept, embracing so
components as well as enviro
research is focused speciﬁcall
could be made to products' e
We recognise that sustainabil
attention with other design is
safety and efﬁcacy are always
interested in how designers a
emerging area of interest. All
treated as strictly conﬁdentia
that could positively identify
organisation they work for, w
material that is released as a r
raw data will be seen only by
survey at the University of Ca
1. About you 1.1 Are you, or have you been, in
medical devices?
1.2 What is your job title?design solutions to meet the demands of the whole system cannot
by their very nature be optimal for any individual parts of the
healthcare system. Deﬁning these key trade-offs is a critical design
challenge, requiring input and negotiation from all members of this
complex system. Similarly, issues that were found through this
research to be important, but were not found to have been
adequately addressed thus far will need to be addressed in the near
future, in particular the elimination of harmful substances such as
mercury from devices themselves. With this in mind, DfE efforts
going forward in the medical device industry should:
 Optimise DfE at a system level, rather than at a single device
level.
 Support designer education on the relevant topics.
 Acknowledge the speciﬁc needs of the medical device industry
around safety, efﬁcacy and reliability.
 Be speciﬁc to the medical device industry and its particular DfE
needs.
The outputs of this study should therefore be used as a foun-
dation for further exploration of the best ways to enable more DfE
activity in the industry.
As an exploratory study, this survey has indicated some valuable
opportunities for further study. This study has not set out to narrow
the domain of ‘medical devices’. However, it is likely that the design
issues faced when developing simple reusable devices differ from
those encountered when designing complicated machinery. Thus, a
future study might explore these different contexts independently.
The sample for this study is small, and a wider scale study might
also elicit some original insights.
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Section Question Question or text Form of data output
1.3 What is the name of the organisation you work for? If
you are freelance, please put ‘Freelance’. If you do not
currently work in themedical device design ﬁeld, please
put the last company you worked for in the area.
Free form text
1.4 What are your organisation's main products or
services?
Free form text
2. Designing for environmental
sustainability
2.1 In your experience, is the impetus to consider
environmental sustainability in the design of medical
devices:
- Increasing
- Remaining about the same
- Decreasing
Choice of one from three
2.2 Please drag the sliders [immediately below the
question] to indicate how signiﬁcant you believe the
following drivers to be in providing impetus for
environmentally conscious design in medical devices.
- Internal company pressure
- Individual choice of designers
- Pressure from government organisations
- Client demand
- Regulatory mandate
- Other
Score from 0 to 100 for each driver. “Other” option
accompanied by free form text ﬁeld
2.3 During the design process for products that you work
with, how important is the explicit consideration of
environmental sustainability? Please choose the
statement that most closely corresponds with how you
work, or make an entry into the “Other” box if none of
these descriptions accurately reﬂect your situation.
- We design for it voluntarily but other things are more
important
- We will design for it only if the project brief demands
or the client speciﬁcally asks for it
- It is not important but we will comply with the law
where we have to
- It is very important, we will make a new or
redesigned product as sustainable as we can
- We stick to some internal policies regarding
environmental credentials, but nothing further
- Other
Choice: one statement out of six. “Other” option
accompanied by free form text ﬁeld
2.4 What do you perceive to be the major barriers to
implementing environmentally conscious design in
medical devices?
Free form text
3. Sustainability concerns: Our work
takes a life cycle approach to
thinking about sustainability in
medical devices.
In the following questions (one part for
each life cycle phase), please indicate
what level of concern each one holds
for your work.
3.1 Raw material sourcing
- Harmful substances in the bill of raw materials
- Use of mercury
- Use of scarce materials (e.g. precious metals)
- Recycled, reused or remanufactured content
- Diversity of raw materials
- Energy sources used in extraction of raw materials
- Processes of extraction
Each item scored on a 1e5 scale, where 1 ¼ issue is
not a concern, 5 ¼ issue is a major concern
3.2 Manufacturing
- Processes used in assembly
- Solid waste produced
- Use of PVC
- Processes used in raw material conversion
- Waste water produced
- Energy sources used in assembly
- Energy sources used in conversion processes
Each item scored on a 1e5 scale, where 1 ¼ issue is
not a concern, 5 ¼ issue is a major concern
3.3 Distribution
- Space efﬁciency of packaging
- Amount of packaging
- Materials used in packaging including recyclability
- Method of transport
- PVC content of packaging
- Distance from production site to buyer
Each item scored on a 1e5 scale, where 1 ¼ issue is
not a concern, 5 ¼ issue is a major concern
3.4 Use
- Lifetime. upgradeability
- Single use components
- Energy consumed during use (including sterilisation
requirements)
- Solid waste produced
- Cos emissions during use
- Waste water produced
Each item scored on a 1e5 scale, where 1 ¼ issue is
not a concern, 5 ¼ issue is a major concern
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(continued )
Section Question Question or text Form of data output
3.5 End of life
- Designed for reuse
- Designed for disassembly
- Designed for recyclability
- Proportion which must be land-ﬁlled or incinerated
- Designed for remanufacture
Each item scored on a 1e5 scale, where 1 ¼ issue is
not a concern, 5 ¼ issue is a major concern
3.6 Are there any issues that are a cause for concern that do
not appear on these lists?
Free form text
4. Sustainability issues that you have
addressed: Have you addressed, or
are you currently addressing, any of
the concerns mentioned in the
previous section during your medical
device design work?
4.1 Raw material sourcing
- Harmful substances in the bill of raw materials
- Use of mercury
- Use of scarce materials (e.g. precious metals)
- Recycled, reused or remanufactured content
- Diversity of raw materials
- Energy sources used in extraction of raw materials
- Processes of extraction
Yes/No response for each item
4.2 Manufacturing
- Processes used in assembly
- Solid waste produced
- Use of PVC
- Processes used in raw material conversion
- Waste water produced
- Energy sources used in assembly
- Energy sources used in conversion processes
Yes/No response for each item
4.3 Distribution
- Space efﬁciency of packaging
- Amount of packaging
- Materials used in packaging including recyclability
- Method of transport
- PVC content of packaging
- Distance from production site to buyer
Yes/No response for each item
4.4 Use
- Lifetime. upgradeability
- Single use components
- Energy consumed during use (including sterilisation
requirements)
- Solid waste produced
- Cos emissions during use
- Waste water produced
Yes/No response for each item
4.5 End of life
- Designed for reuse
- Designed for disassembly
- Designed for recyclability
- Proportion which must be land-ﬁlled or incinerated
- Designed for remanufacture
Yes/No response for each item
4.6 Are there any issues that you have tackled that do not
appear on these lists?
Free form text
4.7 Disregarding other design pressures, what do you
consider to be themost urgent issue to tackle in the area
of environmentally conscious design in medical
devices?
Free form text
5. Further comments: This short section
is for any further thoughts you may
have about environmentally
sustainable design in the medical
device space.
5.1 If you have any experience with or insight into issues
surrounding environmental sustainability in medical
device design, please use this box to leave any
comments.
Free form text
5.2 If you would be willing to talk with us more about this
area of research, please leave your contact details in the
box below.
Free form text
6. Demographic information: Finally,
please tell us a little more about you,
so that we can start to understand
whether particular trends are
associated with location, company
size, and so on. This data is
conﬁdential and you will remain
anonymous. This is the last set of
questions.
6.1 Have you ever worked in another industry? Yes/No
6.2 If you have worked in another industry, what is/was it? Free form text
6.3 Where are you located? Choice: one out of eight location categories
6.4 How many people work at the company you work for?
Please refer to the organisation you named at the
beginning of the survey.
Choice: one out of six size groups
6.5 Which age range do you fall into? Choice: one out of seven age groups
6.6 Are you: [male/female]? Are you: [male/female]
Closing message Thank you for taking the time to complete the survey,
we appreciate your input. Please feel free to pass on the
link to the survey to contacts who may be interested:
[link to survey]. If you are interested in receiving the
results of the survey once the data has been analysed,
please email us at: [email address].
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